the aid library

LIST OPTIONS

Filter

4234

Download (845)

View PDF (1033)

Promoting partner and couples HIV testing using self-test kits in Kenya

H. Thirumurthy, E. Omanga, B. Obonyo et al. (2017) C1

Download (293)

View PDF (420)

Inclusive Solidarity and the Integration of Marginalized People

The Pontifical Academy of Social Sciences (2014) C1

Final Statement

Download (454)

View PDF (687)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (486)

View PDF (714)

Humanitarian inclusion standards for older people and people with disabilities
recommended

Age and Disability Consortium CBM International, HelpAge International,and Handicap International (2018)

The Standard consists of nine key inclusion standards, and seven sets of sector-specific inclusion standards for protection – water, sanitation and hygiene, food security and livelihoods, nutrition, shelter, settlement and household items, health and education. Each standard comes with key actions... more

Download (240)

View PDF (306)

Statistical Yearbook for Asia and the Pacific 2014

United Nations Economic and Social Commission for Asia and the Pacific (2014) C2

Download (313)

View PDF (553)

Health system considerations: when influenza meets COVID-19: preparedness and response measures when COVID-19, influenza and acute respiratory infections coincide in the WHO European Region

World Health Organization WHO, Regional Office of Europe (2020) C_WHO

revised version December 2020

Download (263)

View PDF (314)

Female genital mutilation in the Middle East and North Africa

UN Children's Fund UNICEF (2020) C_UNICEF

Almost 50 million girls and women have undergone FGM in five countries in the Middle East and North Africa, accounting for one quarter of the global total

Download (372)

View PDF (443)

Addressing comorbidity between mental disorders and major noncommunicable diseases

World Health Organization WHO; Regional Office for Europe (2017) C_WHO

Reduced healthy life expectancy due to the high burden of both mental ill health and noncommunicable diseases (NCDs) is a major public health concern in the European Region. The links between mental disorders and major NCDs are well established. In clinical practice, however, mental disorders in pa... more

Download (2212)

View PDF (1195)

Information and Communications Technology Response to the Liberia Ebola Crisis

USAID; Net Hope; GBI (2014)

Desk Review and Recommendations for Private Sector Engagement

Download (363)

View PDF (542)

TB prevention and control care in prisons

M. Doara, D. Choroliani, P. de Colombani World Health Organization, Europe (2014) C_WHO

Chapter 8, Prison and Health, published

Download (1396)

View PDF (2269)

Definitions and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia

World Health Organization; International Diabetes Federation (2006) C_WHO

Download (1058)

View PDF (1291)

Public Health and HIV/AIDS in Cambodia

Dunn, L., Chea; M. and S.Abjorensen Parliamentary Institute of Cambodia (2014) C3

External Link

Epidemiologic and clinical investigations during a chikungunya outbreak in Rio Grande do Norte State, Brazil

Monteiro , J.D.; J. Gardel Valverde , I. Camara Morais et al. (2020) CC

PLOS One November 20, 2020 https://doi.org/10.1371/journal.pone.0241799 . The first autochthonous case of chikungunya virus (CHIKV) infection in Brazil was in September 2014 in the State of Amapá, and from there it rapidly spread across the country. The present study was conducted in 2016 in the st... more

Download (236)

View PDF (351)

Findings and Recommendations from the Noncommunicable Diseases and Injuries (NCDI) Commission of Ethiopia

Federal Democratic Republic of Ethiopia -Ministry of Health (2018) C1

Download (258)

View PDF (237)

Social and Economic Impact of COVID-19

E. Levy Yeyati; F. Filippini The Independent Panel (2021) CC

Background paper 13 The Independent Panel for Pandemic Preparedness and Response May 2021

External Link

Professionalizing Health Logistics in Burkina Faso: Challenges, Implementation and Sustainability

Silve B., A. Ouedraogo Public Health Research (2013) C2

The management of information and logistics is an essential component of health product systems. In a context of limited financial resources and morbidity and mortality sustained by persistent diseases, it is necessary to strengthen health systems through competent resources, especially human resour... more

Download (200)

View PDF (193)

Air pollution and the noncommunicable disease prevention agenda: opportunities for public health and environmental science

Howse, E.; Crane, M.; Hanigan, I. et al. Environmental Research Letters (2021) CC

Air pollution is a major environmental risk factor and contributor to chronic, noncommunicable diseases (NCDs). However, most public health approaches to NCD prevention focus on behavioural and biomedical risk factors, rather than environmental risk factors such as air pollution. This article discus... more

Download (1504)

View PDF (2701)

Sexual and Gender-Based Violence against Refugees, Returnees and Internally Displaced Persons
recommended

UNHCR (2003) C1

Guidelines for Prevention and Reponse

Download (264)

View PDF (383)

HIV and Life skills report

Monitoring and learning unit (2013) C2

Prepared by the monitoring and learning unit

Download (793)

View PDF (1134)

WHO Global Surveillance and Monitoring System for substandard and falsified medical products. Executive Summary

World Health Organization WHO (2017) C_WHO

Humanitarian inclusion standards for older people and people with disabilities recommended

Sexual and Gender-Based Violence against Refugees, Returnees and Internally Displaced Persons recommended

Humanitarian inclusion standards for older people and people with disabilities
recommended

Sexual and Gender-Based Violence against Refugees, Returnees and Internally Displaced Persons
recommended